Geratherm Medical AG

As of June 30, 2023, Geratherm Medical AG carries a market capitalization of 39.35M, placing it among publicly traded companies globally. Its enterprise value stands at 37.01M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Geratherm Medical AG's next confirmed earnings release is scheduled for April 27, 2027.

As of June 30, 2023, Geratherm Medical AG has 5.43M shares outstanding.

These figures are as of June 30, 2023.

As of June 30, 2023, Geratherm Medical AG maintains a current ratio of 13.99, meaning it holds 14.0x the short-term assets needed to cover near-term liabilities.

Over the twelve months ended June 30, 2023, Geratherm Medical AG recorded 492,518.00 in income tax expense.

As of the close on October 22, 2026, Geratherm Medical AG's stock has declined approximately 35.86% over the past 52 weeks. The 50-day moving average sits at 2.36, while the 200-day moving average is 2.65.

As of June 30, 2023, Geratherm Medical AG holds 10.90M in cash and equivalents against 8.15M in total debt, resulting in a net debt position of -571,590.00. Total book value stands at 22.84M, with working capital of 21.88M providing operational flexibility.

These figures cover the twelve months ended June 30, 2023.